Result: The mean of tracking time was 19.42 months, at 6 months after treatment, the percentage of complete response was 16.1%, partial response 63.6%, stable disease 6.8%, progressive disease 13.5%, the overall response rate was 79.7% and the disease control rate was 86.5%.